stem cells

Upbeat prospects for some California clinical trial efforts from CIRM

Asterias-cells

Over at the California Stem Cell Report, David Jensen is reporting on some good news from CIRM for California on the stem cell clinical trial front. Stem cell biotechs Asterias and Capricor have stem cell trials supported by 20+ million in CIRM funding each and have been hitting milestones. These trials are progressing and so far have good safety …

Upbeat prospects for some California clinical trial efforts from CIRM Read More »

A TGIF weekend reading list of new stem cell pubs & headlines

Screen-Shot-2017-04-28-at-1.30.49-PM

In case you have some free time for reading this week, here’s a list containing an assortment of interesting research articles and stem cell headlines. I’ve thrown some oddballs in there too including one article from May 1983, when I was just finishing up junior high. No, I didn’t write it. And no the headline …

A TGIF weekend reading list of new stem cell pubs & headlines Read More »

Burt Northwestern Stem Cell MS Trial Part 2: Marketing ‘Cure’-Like Outcomes?

stem-cells-MS-Northwestern-University

Can science now cure MS in some patients with stem cells or is that near on the horizon? What about stem cells for other serious autoimmune disorders? What are the risks to patients in terms of health, money, and hope? What if patients must find $100,000 or $200,000 just to get into a clinical trial for …

Burt Northwestern Stem Cell MS Trial Part 2: Marketing ‘Cure’-Like Outcomes? Read More »

California legal expert weighs in on court ruling in Stemgenex case

The civil lawsuit against Stemgenex here in California was substantially narrowed by a judge and some of the judge’s comments were surprising in suggesting limitations in how patients may respond to stem cell clinics or other businesses if they are unhappy enough to consider filing suit. For more on the court’s ruling see my previous …

California legal expert weighs in on court ruling in Stemgenex case Read More »

Narrowed Stemgenex suit proceeds as court implies stem cell clinic loopholes

Stemgenex

Can California stem cell clinics make questionable marketing claims about their experimental, non-FDA approved offerings as long as they are not demonstrably false? Do such clinics not bear any legal requirement to provide informed consent to patients? A new court ruling raises such striking questions. San Diego stem cell clinic Stemgenex sells non-FDA approved experimental stem …

Narrowed Stemgenex suit proceeds as court implies stem cell clinic loopholes Read More »

Washington State considers stem cell regenerative medicine funding

ISCRM-Washington-stem-cells

Washington State is considering state funding for regenerative medicine. How cool is that? You can read more about this effort in an opinion piece authored by Washington stem cell researcher, Professor Charles Murry. There’s so much important stem cell research going on that federal funding, private and biotech investors, and philanthropy simply cannot fund it …

Washington State considers stem cell regenerative medicine funding Read More »

Find $250 Easter egg in GMO Sapiens #CRISPR book: here’s a hint

Eierkippen-e1469805974165

Want $250 as well as at least a sliver of science-related glory? Within my book GMO Sapiens on CRISPR and human genetic modification, I’ve hidden a scientific Easter egg. There’s more Easter egg info over here including the rules. If you are the first one to find and properly explain this egg to me after buying the book, you win …

Find $250 Easter egg in GMO Sapiens #CRISPR book: here’s a hint Read More »

Why UC Berkeley deserves the main CRISPR patent

statment_gene_editing-tech

Some months back a USPTO court issued a ruling that most interpreted as meaning the Broad Institute had won the so-called ‘CRISPR patent battle’ in the U.S. and that UC Berkeley, Jennifer Doudna, and Emmanuelle Charpentier had lost. Now this week Berkeley has appealed that ruling. It seems the odds are against Berkeley prevailing in its appeal, but frankly …

Why UC Berkeley deserves the main CRISPR patent Read More »